ASML STEALS Europe’s Iron Throne From Novo Nordisk (Money Printer Goes Burrr)
Bahhh Gawd, that’s Peter Wennink’s music…
Veldhoven, population 46,000. A Dutch town you couldn't pick out of a lineup if it slapped you across the face… and as of Wednesday, the home of the most valuable European company in recorded history. Ever. ASML just printed itself a $674 billion market cap and a permanent spot in the textbooks.
Shares mooned to a peak of 2.3% on Wednesday, eclipsing Novo Nordisk's June 2024 record by a yuge margin. Translation: ASML is now worth more than HSBC and Roche combined. For context, the firm has ripped 50% YTD on nothing more than the dawning realization that you cannot build AI without chips, you cannot build chips without lithography, and you cannot build EUV lithography without driving to a small town outside Eindhoven and paying whatever Christophe Fouquet asks for.
Friendly reminder, for those of you who tuned out the chip story sometime around the third Nvidia split: ASML is the sole supplier of EUV machines. The machine. The $400-million tin-droplet-laser monstrosity the size of a city bus that prints every advanced AI chip in existence. TSMC needs it. Samsung needs it. Intel, currently going full-send on High-NA EUV, especially needs it. The Chinese have been trying to reverse-engineer one for a decade (spoiler: they're not close) and Fouquet just shrugged on TechCrunch last month and said "no one is coming for us." Spoiler: He’s right.
Adding to the mic drop, JPMorgan capitulated on Wednesday and conceded that investors are "behind the curve" on how many tools ASML will sell over the next two years… which you know, took the wind right out the sails of short sellers. UBS yanked its price target from €1,600 to €1,900 and named the stock a top pick. The entire suit choir is officially singing in unison, which is normally the sign to sell… except there is no one left to sell to after recent days (everyone with skin in the game is now long).
Meanwhile, pour one out for the formal Iron Throne holder. Novo Nordisk got its cheeks clapped by Eli Lilly's tirzepatide and a tsunami of compounded Ozempic knockoffs, lost half its market cap in 2025, watched two top execs head for the door in February, and now has the additional indignity of being lapped on the leaderboard by a company that makes the f*cking rocks that print intelligence itself. Novo's CEO told the market it would "get worse before it gets better." Woof.
Meaning, this is what a pickaxe seller during a gold rush looks like… except every miner has unlimited credit, the gold is artificial general intelligence, and the pickaxe costs $400 million and takes 18 months to deliver. ASML is on track to ship 90 EUV tools in 2027. That's 7.5 per month. For a machine no other human being on Earth knows how to build. ASML stays undefeated, friends. Until next time…

At the time of publishing, Stocks.News holds positions in Intel as mentioned in the article.